Endometriosis and cancer
H Kajiyama, S Suzuki, M Yoshihara, S Tamauchi… - Free Radical Biology …, 2019 - Elsevier
Endometriosis, characterized by the presence of extra-uterine endometrium, is a common
gynecologic disorder in reproductive-age women. Although the detailed molecular …
gynecologic disorder in reproductive-age women. Although the detailed molecular …
[HTML][HTML] Oxidative stress-dependent and-independent death of glioblastoma cells induced by non-thermal plasma-exposed solutions
H Tanaka, M Mizuno, Y Katsumata, K Ishikawa… - Scientific reports, 2019 - nature.com
Non-thermal atmospheric pressure plasma has been widely used for preclinical studies in
areas such as wound healing, blood coagulation, and cancer therapy. We previously …
areas such as wound healing, blood coagulation, and cancer therapy. We previously …
Current understanding of plasma-activated solutions for potential cancer therapy
N Yoshikawa, K Nakamura, H Kajiyama - Free Radical Research, 2023 - Taylor & Francis
Cancer therapy consists of multidisciplinary treatment combining surgery, chemotherapy,
radiotherapy, and immunotherapy. Despite the elucidation of cancer mechanisms by …
radiotherapy, and immunotherapy. Despite the elucidation of cancer mechanisms by …
[HTML][HTML] Plasma-activated medium promotes autophagic cell death along with alteration of the mTOR pathway
N Yoshikawa, W Liu, K Nakamura, K Yoshida… - Scientific Reports, 2020 - nature.com
The biological function of non-thermal atmospheric pressure plasma has been widely
accepted in several types of cancer. We previously developed plasma-activated medium …
accepted in several types of cancer. We previously developed plasma-activated medium …
[HTML][HTML] Peritoneal restoration by repurposing vitamin D inhibits ovarian cancer dissemination via blockade of the TGF-β1/thrombospondin-1 axis
K Kitami, M Yoshihara, S Tamauchi, M Sugiyama… - Matrix Biology, 2022 - Elsevier
Ovarian cancer (OvCa), a lethal gynecological malignancy, disseminates to the peritoneum.
Mesothelial cells (MCs) act as barriers in the abdominal cavity, preventing the adhesion of …
Mesothelial cells (MCs) act as barriers in the abdominal cavity, preventing the adhesion of …
ALX1 induces snail expression to promote epithelial-to-mesenchymal transition and invasion of ovarian cancer cells
H Yuan, H Kajiyama, S Ito, N Yoshikawa, T Hyodo… - Cancer research, 2013 - AACR
Ovarian cancer is a highly invasive and metastatic disease with a poor prognosis if
diagnosed at an advanced stage, which is often the case. Recent studies argue that ovarian …
diagnosed at an advanced stage, which is often the case. Recent studies argue that ovarian …
CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway
H Yasui, H Kajiyama, S Tamauchi, S Suzuki… - Clinical & Experimental …, 2020 - Springer
Epithelial ovarian cancer (EOC) is considered to secrete various factors in order to promote
peritoneal dissemination through cell-to-cell interaction between cancer and mesothelial …
peritoneal dissemination through cell-to-cell interaction between cancer and mesothelial …
[HTML][HTML] Reproductive outcomes of 105 malignant ovarian germ cell tumor survivors: a multicenter study
S Tamauchi, H Kajiyama, M Yoshihara, Y Ikeda… - American Journal of …, 2018 - Elsevier
Background Malignant ovarian germ cell tumors usually occur in young women. Until the
1970s, before establishment of systemic chemotherapy, malignant ovarian germ cell tumors …
1970s, before establishment of systemic chemotherapy, malignant ovarian germ cell tumors …
[HTML][HTML] Preclinical verification of the efficacy and safety of aqueous plasma for ovarian cancer therapy
K Nakamura, N Yoshikawa, Y Mizuno, M Ito, H Tanaka… - Cancers, 2021 - mdpi.com
Simple Summary Ovarian cancer is among the most malignant gynecologic cancers, in part
because intraperitoneal recurrence occurs with high frequency due to occult metastasis. We …
because intraperitoneal recurrence occurs with high frequency due to occult metastasis. We …
PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination
Y Peng, H Kajiyama, H Yuan, K Nakamura… - Cancer Letters, 2019 - Elsevier
The mesothelium, covered by a continuous monolayer of mesothelial cells, is the first
protective barrier against metastatic ovarian cancer. However, mesothelial cells release …
protective barrier against metastatic ovarian cancer. However, mesothelial cells release …